BAAR, Switzerland, Feb. 8, 2021 /CNW/ -- Orpha Labs AG today announced its compassionate use program to make ORL-101 available to physicians providing care for Leukocyte Adhesion Deficiency Type II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results